In the second part of the study, we explored the protective effects of EVOO consumption on AD by examining the shared KEGG pathways and GO-BPs influenced by both EVOO and NRF2 activators from clinical trials that are also implicated in AD. The gene discussed is NFE2L2; the disease is Alzheimer disease.